Holen Sie sich die Stockscreener-App
4.89
4.21%
-0.215
Handel nachbörslich:
4.90
0.01
+0.20%
Relay Therapeutics Inc Aktie (RLAY) Neueste Nachrichten
Layoff Tracker: Adaptimmune Downsizes by 33% in Strategic Realignment - BioSpace
Relay Therapeutics (NASDAQ:RLAY) Trading Down 4.8% – Here’s What Happened - Defense World
Relay Therapeutics (NASDAQ:RLAY) Stock Price Down 4.8%Time to Sell? - MarketBeat
(RLAY) Trading Report - Stock Traders Daily
Relay Therapeutics stock hits 52-week low at $5.59 - Investing.com India
Relay Therapeutics stock hits 52-week low at $5.59 By Investing.com - Investing.com UK
Analyzing Valneva (NASDAQ:VALN) and Relay Therapeutics (NASDAQ:RLAY) - Defense World
NKGen Biotech (NYSE:NKGN) versus Relay Therapeutics (NASDAQ:RLAY) Financial Contrast - Defense World
Relay Therapeutics' SWOT analysis: PI3K inhibitor progress fuels stock potential - Investing.com
HC Wainwright Forecasts Strong Price Appreciation for Relay Therapeutics (NASDAQ:RLAY) Stock - Defense World
Research Analysts Offer Predictions for RLAY FY2024 Earnings - MarketBeat
FY2024 Earnings Estimate for RLAY Issued By Leerink Partnrs - Defense World
Relay Therapeutics (NASDAQ:RLAY) Given New $20.00 Price Target at HC Wainwright - MarketBeat
Relay Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times
RLAYRelay Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan
Relay Therapeutics Reports Q3 2024 Results and Advances - TipRanks
Relay Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Highlights - The Manila Times
Relay Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Where are the Opportunities in (RLAY) - Stock Traders Daily
Relay Therapeutics (RLAY) to Release Earnings on Wednesday - MarketBeat
Relay Therapeutics stock hits 52-week low at $5.7 amid market shifts - Investing.com Australia
Relay Therapeutics stock hits 52-week low at $5.7 amid market shifts By Investing.com - Investing.com South Africa
Relay Therapeutics to Announce Third Quarter 2024 Financial Results and Corporate Highlights on November 6, 2024 - The Manila Times
Relay Therapeutics to Announce Third Quarter 2024 Financial Results and Corporate Highlights on November 6, - EIN News
Intrahepatic Cholangiocarcinoma Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, and Key Companies involved by DelveInsight | Xencor, Relay Therapeutics, Kinnate Biopharma, Forma Therapy - Barchart
Institutional owners may consider drastic measures as Relay Therapeutics, Inc.'s (NASDAQ:RLAY) recent US$67m drop adds to long-term losses - Yahoo Finance
Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Several Relay Therapeutics Insiders Sell Shares Sending Potential Negative Signal - Simply Wall St
Relay Therapeutics' SWOT analysis: oncology innovator's stock faces pivotal phase - Investing.com Canada
Relay Therapeutics' SWOT analysis: oncology innovator's stock faces pivotal phase By Investing.com - Investing.com South Africa
Financial Snapshot: Analyzing Relay Therapeutics Inc (RLAY)’s Key Ratio Metrics - The Dwinnex
Relay Therapeutics, Inc. (NASDAQ:RLAY) Short Interest Update - MarketBeat
How did Relay Therapeutics Inc (RLAY) fare last session? - US Post News
Relay Therapeutics (NASDAQ:RLAY) Receives Buy Rating from HC Wainwright - MarketBeat
Relay Therapeutics stock holds price target on FDA approval By Investing.com - Investing.com UK
Relay Therapeutics Inc (RLAY) receives a Buy rating from Jefferies - Knox Daily
Relay Therapeutics (NASDAQ:RLAY) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
Relay Therapeutics Inc: Analyzing RLAY Stock Trends - The InvestChronicle
Relay Therapeutics Inc [NASDAQ: RLAY] Sees Increase in Stock Value - Knox Daily
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):